Soligenix updates medical advisory board for lymphoma drug development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. PANW
2. SPY
3. ULTA
4. GTLB
5. USO
6. CRWD
7. GOOGL
8. MDT
9. AVGO
10. VRTS

Go back to Soligenix updates medical advisory board for lymphoma drug development
Soligenix, Inc. (NASDAQ: SNGX) Delayed: 0.48 -0.27 (36%)
Previous Close $0.75    52 Week High $4.35 
Open $0.60    52 Week Low $0.44 
Day High $0.62    P/E N/A 
Day Low $0.46    EPS $-0.81 
Volume 6,756,876